Course Overview
Ethics is foundational to a digital health industry that helps, not harms. Every one of us working in the field – must have foundational knowledge in ethics to ensure that we realize the full promise of the digitization of healthcare to improve lives, for everyone.
Topics Covered
Meet the Instructors
Learn from DiMe experts and world class guest faculty – including patient experts, applied ethicists from industry, and academia – at the cutting edge of the most difficult ethical questions in digital health.
In this course you will:
Engaging courses
Current, relevant content
Flexible learning
REVIEWS
What learners are saying
-
DIME ACADEMY REVIEW
A digital health technology (DHT) is not a digital measure, and a digital measure is not a DHT?
-
DIME ACADEMY REVIEW
You don’t need to qualify a digital measure in order to use it as a primary endpoint in a pivotal study?
-
DIME ACADEMY REVIEW
As of April 2023, 104 unique sponsor organizations have leveraged digital endpoints in clinical studies?
-
DIME ACADEMY REVIEW
Decentralized clinical trial (DCT) methods increase value by $20M per drug, if applied in both Ph II and III trials?
-
DIME ACADEMY REVIEW
In 2019, the EMA qualified the SV95C digital endpoint for use in pivotal and exploratory drug therapeutics studies for ambulant Duchenne Muscular Dystrophy (DMD) patients?
-
DIME ACADEMY REVIEW
In the recent draft guidance for DCTs, the FDA highlighted the opportunity to leverage digital health technologies (DHTs) in clinical trials?
-
DIME ACADEMY REVIEW
Bellerophon recently received FDA and NMPA endorsement to use a digital measure as the primary endpoint in a pivotal clinical trial?
-
DIME ACADEMY REVIEW
The FDA believes that artificial intelligence (AI) and machine learning (ML) technologies have the potential to transform health care?
-
DIME ACADEMY REVIEW
Real world data (RWD) can also be used to improve the efficiency of clinical trials, even if not used to generate real world evidence (RWE) regarding product effectiveness?
-
DIME ACADEMY REVIEW
Bellerophon recently received FDA and NMPA endorsement to use a digital measure as the primary endpoint in a pivotal clinical trial?
